CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in HYPR — Hyperfine, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in HYPR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$256,817

+$240,999 QoQ

Shares Held

190,235

+1198.8% QoQ

Ownership

0.179%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#18

of 81 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $9,357,274,568 across 81 Medical Devices names. HYPR ranks #76 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	59,674,507	$5,414,864,764
2	MDT	Medtronic plc	8,905,319	$696,663,105
3	SYK	Stryker Corp	2,148,933	$676,570,065
4	BSX	Boston Scientific Corp	9,223,151	$393,644,084
5	EW	Edwards Lifesciences Corp	3,693,034	$334,071,855
6	DXCM	Dexcom Inc	3,439,164	$231,627,694
7	GEHC	GE HealthCare Technologies Inc.	3,129,530	$200,321,215
8	STE	STERIS plc	666,633	$140,372,910

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$256,817	190,235	+1198.8%	Shares	Sole	2026-08-14
2024-09-30	$15,818	14,647	0.0%	Shares	Sole	2024-11-12
2024-06-30	$12,449	14,647	0.0%	Shares	Sole	2024-08-12
2024-03-31	$14,647	14,647	0.0%	Shares	Sole	2024-05-09
2023-12-31	$16,404	14,647	0.0%	Shares	Sole	2024-02-06
2023-09-30	$30,026	14,647	0.0%	Shares	Sole	2023-11-08
2023-06-30	$31,491	14,647	0.0%	Shares	Sole	2023-08-10
2023-03-31	$21,091	14,647	-59.4%	Shares	Sole	2023-05-12
2022-12-31	$30,311	36,085	0.0%	Shares	Sole	2023-02-13
2022-09-30	$29,228	36,085	0.0%	Shares	Sole	2022-11-14
2022-06-30	$80,469	36,085	0.0%	Shares	Sole	2022-08-15
2022-03-31	$127,740	36,085	—	Shares	Sole	2022-05-13
No filing history on record for this holder in this stock.